(+)-catechin multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of FMO5 mRNA CTD PMID:24763279 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FMO5 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of FMO5 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of FMO5 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FMO5 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO FMO5 (Homo sapiens) 6480464 Estradiol results in decreased expression of FMO5 mRNA CTD PMID:20106945 17beta-estradiol decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of FMO5 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO Fmo5 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of FMO5 mRNA CTD PMID:26496021 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO FMO5 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of FMO5 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:20005886 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FMO5 mRNA CTD PMID:32109520 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO FMO5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FMO5 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FMO5 mRNA CTD PMID:16962184 and PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO FMO5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of FMO5 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FMO5 mRNA CTD PMID:18765683 and PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Fmo5 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 3-phenylprop-2-enal increases expression ISO FMO5 (Homo sapiens) 6480464 cinnamaldehyde results in increased expression of FMO5 mRNA CTD PMID:19000754 4,4'-diaminodiphenylmethane increases expression ISO Fmo5 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of FMO5 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of FMO5 mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of FMO5 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of FMO5 mRNA CTD PMID:28973697 acetamide decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 acetamide results in decreased expression of FMO5 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO FMO5 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of FMO5 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 Aflatoxin B1 results in decreased expression of FMO5 mRNA CTD PMID:33354967 aflatoxin B1 decreases expression ISO FMO5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of FMO5 mRNA CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of FMO5 mRNA CTD PMID:19770486 ammonium chloride affects expression ISO Fmo5 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of FMO5 mRNA CTD PMID:16483693 amphetamine increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Amphetamine results in increased expression of FMO5 mRNA CTD PMID:30779732 amphibole asbestos decreases expression ISO FMO5 (Homo sapiens) 6480464 Asbestos and Amphibole results in decreased expression of FMO5 protein CTD PMID:20855422 antirheumatic drug decreases expression ISO FMO5 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of FMO5 mRNA CTD PMID:24449571 azathioprine decreases expression ISO FMO5 (Homo sapiens) 6480464 Azathioprine results in decreased expression of FMO5 mRNA CTD PMID:22623647 belinostat decreases expression ISO FMO5 (Homo sapiens) 6480464 belinostat results in decreased expression of FMO5 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of FMO5 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO FMO5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of FMO5 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO FMO5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of FMO5 mRNA CTD PMID:20106945 more ... benzo[a]pyrene multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 benzo[b]fluoranthene multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FMO5 mRNA CTD PMID:17690111 Benzo[ghi]perylene affects expression EXP 6480464 1 and 12-benzoperylene affects the expression of FMO5 mRNA CTD PMID:26377693 beta-naphthoflavone decreases expression ISO FMO5 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of FMO5 mRNA CTD PMID:22258563 beta-naphthoflavone multiple interactions ISO Fmo5 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FMO5 mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A multiple interactions ISO Fmo5 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of FMO5 mRNA CTD PMID:26496021 bisphenol A affects expression ISO FMO5 (Homo sapiens) 6480464 bisphenol A affects the expression of FMO5 mRNA CTD PMID:30903817 bisphenol A affects expression ISO Fmo5 (Rattus norvegicus) 6480464 bisphenol A affects the expression of FMO5 mRNA CTD PMID:30903817 bisphenol A multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of FMO5 promoter CTD PMID:27334623 bisphenol A decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of FMO5 mRNA and bisphenol A results in decreased expression of FMO5 protein CTD PMID:25181051 and PMID:32145629 buspirone increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Buspirone results in increased expression of FMO5 mRNA CTD PMID:24136188 butanal decreases expression ISO FMO5 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of FMO5 mRNA CTD PMID:26079696 cadmium dichloride affects expression ISO Fmo5 (Rattus norvegicus) 6480464 Cadmium Chloride affects the expression of FMO5 mRNA CTD PMID:22110744 cadmium dichloride increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of FMO5 mRNA CTD PMID:25993096 calcitriol multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FMO5 mRNA CTD PMID:21592394 calcitriol increases expression ISO FMO5 (Homo sapiens) 6480464 Calcitriol results in increased expression of FMO5 mRNA CTD PMID:21592394 captan increases expression EXP 6480464 Captan results in increased expression of FMO5 mRNA CTD PMID:31558096 carbon nanotube affects expression EXP 6480464 Nanotubes and Carbon affects the expression of FMO5 mRNA CTD PMID:25620056 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 cobalt dichloride decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of FMO5 mRNA CTD PMID:24386269 copper(II) chloride decreases expression ISO FMO5 (Homo sapiens) 6480464 cupric chloride results in decreased expression of FMO5 mRNA CTD PMID:17211630 copper(II) sulfate decreases expression ISO FMO5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of FMO5 mRNA CTD PMID:19549813 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of FMO5 mRNA CTD PMID:19770486 and PMID:23830897 cyclosporin A decreases expression ISO FMO5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of FMO5 mRNA CTD PMID:20106945 more ... cyhalothrin increases expression ISO Fmo5 (Rattus norvegicus) 6480464 cyhalothrin results in increased expression of FMO5 mRNA CTD PMID:29727961 D-penicillamine increases expression ISO FMO5 (Homo sapiens) 6480464 Penicillamine results in increased expression of FMO5 mRNA CTD PMID:22843330 dibenz[a,h]anthracene multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 dicrotophos decreases expression ISO FMO5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of FMO5 mRNA CTD PMID:28302478 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO5 mRNA CTD PMID:30529165 diuron increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Diuron results in increased expression of FMO5 mRNA CTD PMID:21551480 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of FMO5 mRNA CTD PMID:15033991 elemental selenium multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA CTD PMID:19244175 endosulfan increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of FMO5 mRNA CTD PMID:29391264 entinostat decreases expression ISO FMO5 (Homo sapiens) 6480464 entinostat results in decreased expression of FMO5 mRNA CTD PMID:27188386 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of FMO5 mRNA CTD PMID:35436446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of FMO5 mRNA CTD PMID:19167417 ethanol affects expression EXP 6480464 Ethanol affects the expression of FMO5 mRNA CTD PMID:30319688 fenofibrate multiple interactions ISO Fmo5 (Rattus norvegicus) 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of FMO5 mRNA CTD PMID:18253720 fenofibrate decreases expression ISO FMO5 (Homo sapiens) 6480464 Fenofibrate results in decreased expression of FMO5 mRNA CTD PMID:25572481 fenthion increases expression EXP 6480464 Fenthion results in increased expression of FMO5 mRNA CTD PMID:34813904 fenvalerate increases expression ISO Fmo5 (Rattus norvegicus) 6480464 fenvalerate results in increased expression of FMO5 mRNA CTD PMID:30307764 flutamide decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of FMO5 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of FMO5 mRNA] CTD PMID:22206623 folpet increases expression EXP 6480464 folpet results in increased expression of FMO5 mRNA CTD PMID:31558096 fumonisin B1 increases expression EXP 6480464 fumonisin B1 results in increased expression of FMO5 mRNA CTD PMID:16221962 gold atom multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of FMO5 mRNA CTD PMID:28433809 gold(0) multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of FMO5 mRNA CTD PMID:28433809 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FMO5 mRNA CTD PMID:36331819 irinotecan affects expression ISO Fmo5 (Rattus norvegicus) 6480464 Irinotecan affects the expression of FMO5 mRNA CTD PMID:20097248 L-ascorbic acid multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of FMO5 mRNA CTD PMID:17639512 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of FMO5 mRNA CTD PMID:25270620 leflunomide increases expression ISO Fmo5 (Rattus norvegicus) 6480464 leflunomide results in increased expression of FMO5 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions EXP 6480464 Lipopolysaccharides inhibits the reaction [Indirubin E804 results in decreased expression of FMO5 mRNA] CTD PMID:23107598 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of FMO5 mRNA CTD PMID:23107598 manganese(II) chloride increases expression ISO Fmo5 (Rattus norvegicus) 6480464 manganese chloride results in increased expression of FMO5 mRNA CTD PMID:28801915 manganese(II) chloride decreases methylation ISO Fmo5 (Rattus norvegicus) 6480464 manganese chloride results in decreased methylation of FMO5 gene CTD PMID:28801915 methapyrilene decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of FMO5 mRNA CTD PMID:30467583 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of FMO5 mRNA CTD PMID:18502557 N-nitrosodiethylamine multiple interactions ISO Fmo5 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FMO5 mRNA and [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of FMO5 mRNA CTD PMID:18164116 and PMID:18253720 N-Nitrosopyrrolidine decreases expression ISO FMO5 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of FMO5 mRNA CTD PMID:32234424 nickel atom decreases expression ISO FMO5 (Homo sapiens) 6480464 Nickel results in decreased expression of FMO5 mRNA CTD PMID:24768652 and PMID:25583101 nitrofen increases expression ISO Fmo5 (Rattus norvegicus) 6480464 nitrofen results in increased expression of FMO5 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO FMO5 (Homo sapiens) 6480464 methyleugenol results in decreased expression of FMO5 mRNA CTD PMID:32234424 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of FMO5 mRNA CTD PMID:17562736 paracetamol decreases expression ISO FMO5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of FMO5 mRNA CTD PMID:29067470 pentanal decreases expression ISO FMO5 (Homo sapiens) 6480464 pentanal results in decreased expression of FMO5 mRNA CTD PMID:26079696 perfluorononanoic acid decreases expression ISO FMO5 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of FMO5 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO FMO5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of FMO5 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO FMO5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of FMO5 mRNA CTD PMID:33772556 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FMO5 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO FMO5 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of FMO5 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO FMO5 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of FMO5 mRNA CTD PMID:33772556 phenformin increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Phenformin results in increased expression of FMO5 mRNA CTD PMID:31324951 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of FMO5 mRNA and Phenobarbital results in increased expression of FMO5 protein CTD PMID:19270015 and PMID:28541575 phenobarbital increases expression ISO FMO5 (Homo sapiens) 6480464 Phenobarbital results in increased expression of FMO5 protein CTD PMID:28541575 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of FMO5 mRNA CTD PMID:23091169 phorbol 13-acetate 12-myristate multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FMO5 mRNA CTD PMID:16979875 phosgene affects expression EXP 6480464 Phosgene affects the expression of FMO5 mRNA CTD PMID:16300373 pinostrobin decreases phosphorylation ISO FMO5 (Homo sapiens) 6480464 pinostrobin results in decreased phosphorylation of FMO5 protein CTD PMID:37164308 pirinixic acid multiple interactions ISO FMO5 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FMO5 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of FMO5 mRNA CTD PMID:17426115 more ... pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FMO5 mRNA CTD PMID:16985257 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of FMO5 mRNA CTD PMID:23608068 propanal decreases expression ISO FMO5 (Homo sapiens) 6480464 propionaldehyde results in decreased expression of FMO5 mRNA CTD PMID:26079696 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of FMO5 mRNA CTD PMID:21278054 quartz decreases expression ISO FMO5 (Homo sapiens) 6480464 Quartz results in decreased expression of FMO5 mRNA CTD PMID:27917503 quercetin multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of FMO5 mRNA CTD PMID:17639512 quercetin decreases expression ISO FMO5 (Homo sapiens) 6480464 Quercetin results in decreased expression of FMO5 mRNA CTD PMID:21632981 quercetin increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Quercetin results in increased expression of FMO5 mRNA CTD PMID:18095365 resveratrol multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of FMO5 mRNA CTD PMID:23557933 riddelliine increases expression ISO Fmo5 (Rattus norvegicus) 6480464 riddelliine results in increased expression of FMO5 mRNA CTD PMID:18047722 rotenone increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Rotenone results in increased expression of FMO5 mRNA CTD PMID:28374803 selenium atom multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA CTD PMID:19244175 senecionine decreases expression ISO FMO5 (Homo sapiens) 6480464 senecionine results in decreased expression of FMO5 mRNA CTD PMID:26100227 Senkirkine decreases expression ISO FMO5 (Homo sapiens) 6480464 senkirkine results in decreased expression of FMO5 mRNA CTD PMID:26100227 silicon dioxide decreases expression ISO FMO5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of FMO5 mRNA and Silicon Dioxide results in decreased expression of FMO5 mRNA CTD PMID:25895662 and PMID:27917503 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of FMO5 mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO FMO5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of FMO5 mRNA CTD PMID:29301061 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of FMO5 mRNA CTD PMID:37682722 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of FMO5 mRNA CTD PMID:31558096 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of FMO5 mRNA CTD PMID:20937368 Tesaglitazar decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 tesaglitazar results in decreased expression of FMO5 mRNA CTD PMID:21515302 testosterone increases expression ISO FMO5 (Homo sapiens) 6480464 Testosterone results in increased expression of FMO5 mRNA CTD PMID:21592394 testosterone multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FMO5 mRNA CTD PMID:21592394 tetrachloroethene decreases expression EXP 6480464 Tetrachloroethylene results in decreased expression of FMO5 mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FMO5 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of FMO5 mRNA CTD PMID:31150632 thioacetamide decreases expression ISO Fmo5 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of FMO5 mRNA CTD PMID:34492290 trichloroethene increases expression ISO Fmo5 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of FMO5 mRNA CTD PMID:33387578 Triptolide affects expression ISO Fmo5 (Rattus norvegicus) 6480464 triptolide affects the expression of FMO5 protein CTD PMID:32519852 triptonide increases expression EXP 6480464 triptonide results in increased expression of FMO5 mRNA CTD PMID:33045310 troglitazone decreases expression ISO FMO5 (Homo sapiens) 6480464 troglitazone results in decreased expression of FMO5 mRNA CTD PMID:19631733 and PMID:25572481 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of FMO5 mRNA CTD PMID:35537566 urethane decreases expression ISO FMO5 (Homo sapiens) 6480464 Urethane results in decreased expression of FMO5 mRNA CTD PMID:28818685 valproic acid decreases expression ISO FMO5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of FMO5 mRNA CTD PMID:29154799 vitamin E multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA CTD PMID:19244175 vitamin E decreases expression ISO FMO5 (Homo sapiens) 6480464 Vitamin E results in decreased expression of FMO5 mRNA CTD PMID:19244175 zinc atom multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FMO5 mRNA CTD PMID:16979875 zinc pyrithione decreases expression ISO FMO5 (Homo sapiens) 6480464 pyrithione zinc results in decreased expression of FMO5 mRNA CTD PMID:21424779 zinc pyrithione increases expression ISO FMO5 (Homo sapiens) 6480464 pyrithione zinc results in increased expression of FMO5 mRNA CTD PMID:21424779 zinc(0) multiple interactions ISO FMO5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FMO5 mRNA CTD PMID:16979875